{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T07:28:39Z","timestamp":1753601319541,"version":"3.41.0"},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15132","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:55:06Z","timestamp":1749124506000},"page":"1-6","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinally extensive transverse myelitis after pembrolizumab and lenvatinib therapy for a rare subtype of renal cell carcinoma: A case report"],"prefix":"10.3892","volume":"30","author":[{"given":"Mateusz","family":"Pi\u0119tak","sequence":"first","affiliation":[{"name":"Department of Genitourinary Oncology, Maria Sk\u0142odowska\u2011Curie National Research Institute of Oncology, 02\u2011781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kruczyk","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, Maria Sk\u0142odowska\u2011Curie National Research Institute of Oncology, 02\u2011781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Doma\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, Maria Sk\u0142odowska\u2011Curie National Research Institute of Oncology, 02\u2011781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadwiga","family":"Jarosi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, Maria Sk\u0142odowska\u2011Curie National Research Institute of Oncology, 02\u2011781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ho\u0142dakowska","sequence":"additional","affiliation":[{"name":"1st Department of Radiology, Maria Sk\u0142odowska\u2011Curie National Research Institute of Oncology, 02\u2011781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Demkow","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, Maria Sk\u0142odowska\u2011Curie National Research Institute of Oncology, 02\u2011781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Kucharz","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Oncology, Maria Sk\u0142odowska\u2011Curie National Research Institute of Oncology, 02\u2011781 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"key20250703131021_b1-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"574271","DOI":"10.3389\/fimmu.2020.574271","article-title":"The use of immune checkpoint inhibitors in oncology and the occurrence of AKI: Where do we stand?","volume":"11","author":"Franzin","year":"2020","journal-title":"Front Immunol"},{"key":"key20250703131021_b2-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"key20250703131021_b3-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.001","article-title":"Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature","volume":"73","author":"Cuzzubbo","year":"2017","journal-title":"Eur J Cancer"},{"key":"key20250703131021_b4-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/WCO.0000000000000093","article-title":"Longitudinally extensive transverse myelitis","volume":"27","author":"Tobin","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"key20250703131021_b5-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1352458511406165","article-title":"The differential diagnosis of longitudinally extensive transverse myelitis","volume":"18","author":"Kitley","year":"2012","journal-title":"Mult Scler"},{"key":"key20250703131021_b6-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s12276-024-01291-2","article-title":"Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma","volume":"56","author":"Lee","year":"2024","journal-title":"Exp Mol Med"},{"key":"key20250703131021_b7-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"key20250703131021_b8-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1003270","DOI":"10.3389\/fneur.2022.1003270","article-title":"Drug-related immune-mediated myelopathies","volume":"13","author":"Gritsch","year":"2022","journal-title":"Front Neurol"},{"key":"key20250703131021_b9-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1093\/brain\/113.5.1269","article-title":"A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications","volume":"113","author":"McLean","year":"1990","journal-title":"Brain"},{"key":"key20250703131021_b10-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s42466-020-0051-z","article-title":"S1 guidelines \u2018lumbar puncture and cerebrospinal fluid analysis\u2019 (abridged and translated version)","volume":"2","author":"Tumani","year":"2020","journal-title":"Neurol Res Pract"},{"key":"key20250703131021_b11-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"7649","DOI":"10.3390\/ijms23147649","article-title":"MiTF\/TFE translocation renal cell carcinomas: From clinical entities to molecular insights","volume":"23","author":"Simonaggio","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20250703131021_b12-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/00313021003767348","article-title":"Xp11 translocation renal cell carcinoma","volume":"42","author":"Ross","year":"2010","journal-title":"Pathology"},{"key":"key20250703131021_b13-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.5858\/arpa.2015-0196-RA","article-title":"MiT family translocation-associated renal cell carcinoma: A contemporary update with emphasis on morphologic, immunophenotypic, and molecular mimics","volume":"139","author":"Magers","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"key20250703131021_b14-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/dc.23839","article-title":"Cyto-histological correlation of Xp11.2 translocation\/TFE3 gene fusion associated renal cell carcinoma: Report of a case with review of literature","volume":"46","author":"Manucha","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"key20250703131021_b15-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.2005.04.4693","article-title":"Translocation carcinomas of the kidney after chemotherapy in childhood","volume":"24","author":"Argani","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20250703131021_b16-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S1470-2045(15)00544-6","article-title":"Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: A multicentre, phase 1b study","volume":"17","author":"Antonia","year":"2016","journal-title":"Lancet Oncol"},{"key":"key20250703131021_b17-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12883-022-02576-7","article-title":"Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: Case report","volume":"22","author":"Moodie","year":"2022","journal-title":"BMC Neurol"},{"key":"key20250703131021_b18-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: From pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J Neuroinflammation"},{"key":"key20250703131021_b19-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1130313","DOI":"10.3389\/fneur.2023.1130313","article-title":"Case series: Immune checkpoint inhibitor-induced transverse myelitis","volume":"14","author":"Chatterton","year":"2023","journal-title":"Front Neurol"},{"key":"key20250703131021_b20-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"e967","DOI":"10.1212\/NXI.0000000000000967","article-title":"Longitudinally extensive myelitis associated with immune checkpoint inhibitors","volume":"8","author":"Picca","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"key20250703131021_b21-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/ITT.S126227","article-title":"Clinical features, predictive correlates, and pathophysiology of immune-related adverse events in immune checkpoint inhibitor treatments in cancer: A short review","volume":"6","author":"Yoest","year":"2017","journal-title":"Immunotargets Ther"},{"key":"key20250703131021_b22-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","article-title":"Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Thompson","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"key20250703131021_b23-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40425-018-0471-2","article-title":"Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation","volume":"6","author":"Chang","year":"2018","journal-title":"J Immunother Cancer"},{"key":"key20250703131021_b24-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40425-018-0393-z","article-title":"Neurologic immune-related adverse events associated with adjuvant ipilimumab: Report of two cases","volume":"6","author":"Garcia","year":"2018","journal-title":"J Immunother Cancer"},{"key":"key20250703131021_b25-ol-30-2-15132","article-title":"Perez & Brady's principles and practice of radiation oncology","author":"Halperin","year":"2013","edition":"6th"},{"key":"key20250703131021_b26-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.ijrobp.2007.11.075","article-title":"The radiation dose-response of the human spinal cord","volume":"71","author":"Schultheiss","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131021_b27-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-1789.2001.00408.x","article-title":"Pathology of radiation myelopathy","volume":"21","author":"Okada","year":"2001","journal-title":"Neuropathology"},{"key":"key20250703131021_b28-ol-30-2-15132","first-page":"1576","article-title":"Radiation-induced myelitis: Initial and follow-up MRI and clinical features in patients at a single tertiary care institution during 20 years","volume":"39","author":"Khan","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"key20250703131021_b29-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clon.2005.03.004","article-title":"Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: A review of the literature and implications for practice","volume":"17","author":"Seddon","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20250703131021_b30-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0360-3016(84)90408-5","article-title":"The Franz Buschke lecture: Late effects of chemotherapy and radiation therapy: A new hypothesis","volume":"10","author":"Rubin","year":"1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131021_b31-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0360-3016(98)00107-2","article-title":"Radiation myelopathy following transplantation and radiotherapy for non-Hodgkin's lymphoma","volume":"41","author":"Chao","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131021_b32-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40425-016-0138-9","article-title":"Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients","volume":"4","author":"Sridharan","year":"2016","journal-title":"J Immunother Cancer"},{"key":"key20250703131021_b33-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1158\/1078-0432.CCR-12-1175","article-title":"Optimizing cancer treatments to induce an acute immune response: Radiation Abscopal effects, PAMPs, and DAMPs","volume":"18","author":"Ludgate","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20250703131021_b34-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41571-018-0046-7","article-title":"Safety of combining radiotherapy with immune-checkpoint inhibition","volume":"15","author":"Hwang","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"key20250703131021_b35-ol-30-2-15132","doi-asserted-by":"publisher","first-page":"bcr1020103444","DOI":"10.1136\/bcr.10.2010.3444","article-title":"Diagnosis of longitudinally extensive transverse myelitis","volume":"2011","author":"Nightingale","year":"2011","journal-title":"BMJ Case Rep"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:10:29Z","timestamp":1751537429000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15132","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2025,6,5]]}}}